Guryanov I.; Orlandin A.; Viola A.; Biondi B.; Badocco D.; Formaggio F.; Ricci A.; Cabri W., Overcoming Chemical Challenges in the Solid-Phase Synthesis of High-Purity GnRH Antagonist Degarelix. Part 1, «ORGANIC PROCESS RESEARCH & DEVELOPMENT», 2019, 23, pp. 2746 - 2753 [articolo]
Brevetto n. EP19207738, Process for the Manufacture of Derivatized Amino Acids.
Brevetto n. EP19161404, Process for the preparation of Degarelix.
Brevetto n. WO2019202057, A Method for Production of High Purity Icatibant".
Brevetto n. WO2018150386, An Improved Process for the Preparation of Boronic Acid Esters.
Brevetto n. WO2018158697, An Improved Process for the Preparation of Ixazomib citrate.
Brevetto n. IN201811024212, An Improved Process for The Preparation of Venetoclax.
Brevetto n. US11396533, Process for The Manufacture of GLP-1 Analogues.
Brevetto n. WO2019175173, Process for the Manufacture of PTHrP Analogue.
Brevetto n. IN201811034524, Process for the Preparation of Acalabrutinib And Its Intermediates".
Brevetto n. US11014919, Process for the preparation of alectinib.
Brevetto n. EP3512835, a A Process For Purification of Carfilzomib Intermediate.
Brevetto n. US10544109, A Process For The Preparation Of Xylene Linked Cyclam Compounds.
Brevetto n. US10577433, An Improved Process For The Preparation of Sugammadex Which Involves The Use of a Salt Of 3-mercapto Propionic Acid, Preferably The Di Sodium Salt Of 3-mercapto Propionic Acid.
Cabri W, fight against Onchocerchiasis/Lymphatic Filiaris and Malaria. Avermectin ans Artemisinin, Lead Compound from Nature, «LA CHIMICA E L'INDUSTRIA», 2016, 98, pp. 48 - 51 [replica/breve intervento]
